Formamide → 10-Bromo-9-fluoro-3-[(2-methylpyrazol-3-yl)methyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-2-carboxamide
反応式
[Br:1][C:2]1[C:3]([F:27])=[CH:4][C:5]2[O:11][CH2:10][CH2:9][N:8]3[C:12]([CH2:19][C:20]4[N:24]([CH3:25])[N:23]=[CH:22][CH:21]=4)=[C:13]([C:15]([O:17]C)=O)[N:14]=[C:7]3[C:6]=2[CH:26]=1.C[O-].[Na+].C([NH2:33])=O>>[Br:1][C:2]1[C:3]([F:27])=[CH:4][C:5]2[O:11][CH2:10][CH2:9][N:8]3[C:12]([CH2:19][C:20]4[N:24]([CH3:25])[N:23]=[CH:22][CH:21]=4)=[C:13]([C:15]([NH2:33])=[O:17])[N:14]=[C:7]3[C:6]=2[CH:26]=1参加物
4
反応物 3
生成物 1
実験手順
10-bromo-9-fluoro-3-((1-methyl-1H-pyrazol-5-yl)methyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide was prepared similarly to as described in General Procedure L. Methyl 10-bromo-9-fluoro-3-((1-methyl-1H-pyrazol-5-yl)methyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxylate was reacted with sodium methoxide and formamide to afford 11 mg (11% crude yield) of the crude title compound which was carried forward without further purification.
後処理
- custom10-bromo-9-fluoro-3-((1-methyl-1H-pyrazol-5-yl)methyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide was prepared similarly
出典と根拠
- ORDレコード
- ord-16e6281abb3c4e5bb3b6367d6c728942
- 出典データセット
- uspto-grants-2015_05
- 特許番号
- US09034866B2
反応ノート
読み込み中…